REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bioseborganics CIA Ltda (Ecuador)

Main Activities: Chemical and Allied Products Merchant Wholesalers
Full name: Bioseborganics CIA Ltda Profile Updated: February 07, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Bioseborganics CIA Ltda is an enterprise located in Ecuador, with the main office in Ibarra. It operates in the Chemical and Allied Products Merchant Wholesalers industry. Bioseborganics CIA Ltda was incorporated on January 18, 2012. The total number of employees is currently 12 (2024). In 2024, the company reported a net sales revenue increase of 29.85%. Its total assets grew by 2.92% over the same period. The enterprise’s net profit margin decreased by 2.84% in 2024.

Headquarters
Mejia 8-33
Ibarra; Imbabura;

Contact Details: Purchase the Bioseborganics CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Bioseborganics CIA Ltda report to view the information.
Registered Capital:
Purchase the Bioseborganics CIA Ltda report to view the information.
Financial Auditors:
Purchase the Bioseborganics CIA Ltda report to view the information.
Incorporation Date:
January 18, 2012
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
49.5%
Purchase this report to view the information.
49.5%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Bioseborganics CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
29.85%▲
Total operating revenue
29.85%▲
Operating profit (EBIT)
-1%▼
EBITDA
-1.87%▼
Net Profit (Loss) for the Period
-2.7%▼
Total assets
2.92%▲
Total equity
-18.26%▼
Operating Profit Margin (ROS)
-3.33%▼
Net Profit Margin
-2.84%▼
Return on Equity (ROE)
3.6%▲
Debt to Equity Ratio
20.6%▲
Quick Ratio
1.11%▲
Cash Ratio
0.6%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo